Another study found that the acquisition of STAG2 mutant clones makes TNFα-induced pro-survival NF-κB signaling become the major pathway for MDS HSCs’ survival, rather than BCL2-mediated anti-apoptotic pathways, resulting in resistance to venetoclax [208]. The gene discussed is STAG2; the disease is myelodysplastic syndrome.